Toll Free: 1-888-928-9744

United States End-Stage Kidney Disease Treatment Industry 2018 Market Research Report

Published: Mar, 2018 | Pages: 96 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States End-Stage Kidney Disease Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of End-Stage Kidney Disease Treatment in these regions, from 2013 to 2025 (forecast).

United States End-Stage Kidney Disease Treatment market competition by top manufacturers/players, with End-Stage Kidney Disease Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    BLR Bio LLC
    CTI BioPharma Corp
    F. Hoffmann-La Roche Ltd
    Novartis AG
    Prolong Pharmaceuticals LLC
    VESSL Therapeutics Ltd
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    MK-3866
    Pacritinib
    Sanguinate
    Tesidolumab
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States End-Stage Kidney Disease Treatment Market Report 2018
1 End-Stage Kidney Disease Treatment Overview
    1.1 Product Overview and Scope of End-Stage Kidney Disease Treatment
    1.2 Classification of End-Stage Kidney Disease Treatment by Product Category
        1.2.1 United States End-Stage Kidney Disease Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
        1.2.2 United States End-Stage Kidney Disease Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
        1.2.3 MK-3866
        1.2.4 Pacritinib
        1.2.5 Sanguinate
        1.2.6 Tesidolumab
        1.2.7 Others
    1.3 United States End-Stage Kidney Disease Treatment Market by Application/End Users
        1.3.1 United States End-Stage Kidney Disease Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 United States End-Stage Kidney Disease Treatment Market by Region
        1.4.1 United States End-Stage Kidney Disease Treatment Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 The West End-Stage Kidney Disease Treatment Status and Prospect (2013-2025)
        1.4.3 Southwest End-Stage Kidney Disease Treatment Status and Prospect (2013-2025)
        1.4.4 The Middle Atlantic End-Stage Kidney Disease Treatment Status and Prospect (2013-2025)
        1.4.5 New England End-Stage Kidney Disease Treatment Status and Prospect (2013-2025)
        1.4.6 The South End-Stage Kidney Disease Treatment Status and Prospect (2013-2025)
        1.4.7 The Midwest End-Stage Kidney Disease Treatment Status and Prospect (2013-2025)
    1.5 United States Market Size (Value and Volume) of End-Stage Kidney Disease Treatment (2013-2025)
        1.5.1 United States End-Stage Kidney Disease Treatment Sales and Growth Rate (2013-2025)
        1.5.2 United States End-Stage Kidney Disease Treatment Revenue and Growth Rate (2013-2025)

2 United States End-Stage Kidney Disease Treatment Market Competition by Players/Suppliers
    2.1 United States End-Stage Kidney Disease Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
    2.2 United States End-Stage Kidney Disease Treatment Revenue and Share by Players/Suppliers (2013-2018)
    2.3 United States End-Stage Kidney Disease Treatment Average Price by Players/Suppliers (2013-2018)
    2.4 United States End-Stage Kidney Disease Treatment Market Competitive Situation and Trends
        2.4.1 United States End-Stage Kidney Disease Treatment Market Concentration Rate
        2.4.2 United States End-Stage Kidney Disease Treatment Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers End-Stage Kidney Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 United States End-Stage Kidney Disease Treatment Sales (Volume) and Revenue (Value) by Region (2013-2018)
    3.1 United States End-Stage Kidney Disease Treatment Sales and Market Share by Region (2013-2018)
    3.2 United States End-Stage Kidney Disease Treatment Revenue and Market Share by Region (2013-2018)
    3.3 United States End-Stage Kidney Disease Treatment Price by Region (2013-2018)

4 United States End-Stage Kidney Disease Treatment Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
    4.1 United States End-Stage Kidney Disease Treatment Sales and Market Share by Type (Product Category) (2013-2018)
    4.2 United States End-Stage Kidney Disease Treatment Revenue and Market Share by Type (2013-2018)
    4.3 United States End-Stage Kidney Disease Treatment Price by Type (2013-2018)
    4.4 United States End-Stage Kidney Disease Treatment Sales Growth Rate by Type (2013-2018)

5 United States End-Stage Kidney Disease Treatment Sales (Volume) by Application (2013-2018)
    5.1 United States End-Stage Kidney Disease Treatment Sales and Market Share by Application (2013-2018)
    5.2 United States End-Stage Kidney Disease Treatment Sales Growth Rate by Application (2013-2018)
    5.3 Market Drivers and Opportunities

6  United States End-Stage Kidney Disease Treatment Players/Suppliers Profiles and Sales Data
    6.1 BLR Bio LLC
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 BLR Bio LLC End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        6.1.4 Main Business/Business Overview
    6.2 CTI BioPharma Corp
        6.2.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        6.2.4 Main Business/Business Overview
    6.3 F. Hoffmann-La Roche Ltd
        6.3.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        6.3.4 Main Business/Business Overview
    6.4 Novartis AG
        6.4.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Novartis AG End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        6.4.4 Main Business/Business Overview
    6.5 Prolong Pharmaceuticals LLC
        6.5.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        6.5.4 Main Business/Business Overview
    6.6 VESSL Therapeutics Ltd
        6.6.2 End-Stage Kidney Disease Treatment Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
        6.6.4 Main Business/Business Overview
    ...

7 End-Stage Kidney Disease Treatment Manufacturing Cost Analysis
    7.1 End-Stage Kidney Disease Treatment Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of End-Stage Kidney Disease Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 End-Stage Kidney Disease Treatment Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of End-Stage Kidney Disease Treatment Major Manufacturers in 2017
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States End-Stage Kidney Disease Treatment Market Size (Value and Volume) Forecast (2018-2025)
    11.1 United States End-Stage Kidney Disease Treatment Sales Volume, Revenue Forecast (2018-2025)
    11.2 United States End-Stage Kidney Disease Treatment Sales Volume Forecast by Type (2018-2025)
    11.3 United States End-Stage Kidney Disease Treatment Sales Volume Forecast by Application (2018-2025)
    11.4 United States End-Stage Kidney Disease Treatment Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of End-Stage Kidney Disease Treatment
    Figure United States End-Stage Kidney Disease Treatment Market Size (K Pcs) by Type (2013-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume Market Share by Type (Product Category) in 2017
    Figure MK-3866 Product Picture
    Figure Pacritinib Product Picture
    Figure Sanguinate Product Picture
    Figure Tesidolumab Product Picture
    Figure Others Product Picture
    Figure United States End-Stage Kidney Disease Treatment Market Size (K Pcs) by Application (2013-2025)
    Figure United States Sales Market Share of End-Stage Kidney Disease Treatment by Application in 2017
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure United States End-Stage Kidney Disease Treatment Market Size (Million USD) by Region (2013-2025)
    Figure The West End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southwest End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Middle Atlantic End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure New England End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The South of US End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure The Midwest End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales (K Pcs) and Growth Rate (2013-2025)
    Figure United States End-Stage Kidney Disease Treatment Revenue (Million USD) and Growth Rate (2013-2025)
    Figure United States End-Stage Kidney Disease Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 United States End-Stage Kidney Disease Treatment Sales Share by Players/Suppliers
    Figure 2017 United States End-Stage Kidney Disease Treatment Sales Share by Players/Suppliers
    Figure United States End-Stage Kidney Disease Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 United States End-Stage Kidney Disease Treatment Revenue Share by Players/Suppliers
    Figure 2017 United States End-Stage Kidney Disease Treatment Revenue Share by Players/Suppliers
    Table United States Market End-Stage Kidney Disease Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
    Figure United States Market End-Stage Kidney Disease Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017
    Figure United States End-Stage Kidney Disease Treatment Market Share of Top 3 Players/Suppliers
    Figure United States End-Stage Kidney Disease Treatment Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers End-Stage Kidney Disease Treatment Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers End-Stage Kidney Disease Treatment Product Category
    Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) by Region (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales Share by Region (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Share by Region (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Region in 2017
    Table United States End-Stage Kidney Disease Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Revenue Share by Region (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Revenue Market Share by Region (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Revenue Market Share by Region in 2017
    Table United States End-Stage Kidney Disease Treatment Price (USD/Pcs) by Region (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) by Type (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales Share by Type (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Share by Type (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Type in 2017
    Table United States End-Stage Kidney Disease Treatment Revenue  (Million USD) and Market Share by Type (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of End-Stage Kidney Disease Treatment by Type (2013-2018)
    Figure Revenue Market Share of End-Stage Kidney Disease Treatment by Type in 2017
    Table United States End-Stage Kidney Disease Treatment Price (USD/Pcs) by Types (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Growth Rate by Type (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales (K Pcs) by Application (2013-2018)
    Table United States End-Stage Kidney Disease Treatment Sales Market Share by Application (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Application (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Market Share by Application in 2017
    Table United States End-Stage Kidney Disease Treatment Sales Growth Rate by Application (2013-2018)
    Figure United States End-Stage Kidney Disease Treatment Sales Growth Rate by Application (2013-2018)
    Table BLR Bio LLC Basic Information List
    Table BLR Bio LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure BLR Bio LLC End-Stage Kidney Disease Treatment Sales Growth Rate (2013-2018)
    Figure BLR Bio LLC End-Stage Kidney Disease Treatment Sales Market Share in United States (2013-2018)
    Figure BLR Bio LLC End-Stage Kidney Disease Treatment Revenue Market Share in United States (2013-2018)
    Table CTI BioPharma Corp Basic Information List
    Table CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales Growth Rate (2013-2018)
    Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Sales Market Share in United States (2013-2018)
    Figure CTI BioPharma Corp End-Stage Kidney Disease Treatment Revenue Market Share in United States (2013-2018)
    Table F. Hoffmann-La Roche Ltd Basic Information List
    Table F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales Growth Rate (2013-2018)
    Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Sales Market Share in United States (2013-2018)
    Figure F. Hoffmann-La Roche Ltd End-Stage Kidney Disease Treatment Revenue Market Share in United States (2013-2018)
    Table Novartis AG Basic Information List
    Table Novartis AG End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Novartis AG End-Stage Kidney Disease Treatment Sales Growth Rate (2013-2018)
    Figure Novartis AG End-Stage Kidney Disease Treatment Sales Market Share in United States (2013-2018)
    Figure Novartis AG End-Stage Kidney Disease Treatment Revenue Market Share in United States (2013-2018)
    Table Prolong Pharmaceuticals LLC Basic Information List
    Table Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales Growth Rate (2013-2018)
    Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Sales Market Share in United States (2013-2018)
    Figure Prolong Pharmaceuticals LLC End-Stage Kidney Disease Treatment Revenue Market Share in United States (2013-2018)
    Table VESSL Therapeutics Ltd Basic Information List
    Table VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales Growth Rate (2013-2018)
    Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Sales Market Share in United States (2013-2018)
    Figure VESSL Therapeutics Ltd End-Stage Kidney Disease Treatment Revenue Market Share in United States (2013-2018)
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of End-Stage Kidney Disease Treatment
    Figure Manufacturing Process Analysis of End-Stage Kidney Disease Treatment
    Figure End-Stage Kidney Disease Treatment Industrial Chain Analysis
    Table Raw Materials Sources of End-Stage Kidney Disease Treatment Major Players/Suppliers in 2017
    Table Major Buyers of End-Stage Kidney Disease Treatment
    Table Distributors/Traders List
    Figure United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Revenue  (Million USD) and Growth Rate Forecast (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Price (USD/Pcs) Trend Forecast (2018-2025)
    Table United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Type in 2025
    Table United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Application in 2025
    Table United States End-Stage Kidney Disease Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025)
    Table United States End-Stage Kidney Disease Treatment Sales Volume Share Forecast by Region (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume Share Forecast by Region (2018-2025)
    Figure United States End-Stage Kidney Disease Treatment Sales Volume Share Forecast by Region in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $3800
Multi User - US $7600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify